
Microbot Medical MBOT
$ 1.81
-2.96%
Quarterly report 2025-Q3
added 11-12-2025
Microbot Medical Interest Expense 2011-2026 | MBOT
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Microbot Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 2 K | 237 K | 333 K | 506 K | 1.3 M | 1.17 M | 50.2 K | 71.4 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.3 M | 2 K | 458 K |
Quarterly Interest Expense Microbot Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 316 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -169 K | - | 27.1 K | 128 | 27.9 K | - | 107 K | 146 K | 185 K | - | 311 K | 343 K | 380 K | 2.51 M | 382 K | 393 K | 10.1 K | 4.03 M | 11.4 K | 14.2 K | 14.4 K | - | 16.6 K | 19.8 K | 20.2 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.03 M | -169 K | 414 K |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M | ||
|
Baxter International
BAX
|
408 M | $ 20.1 | 1.85 % | $ 10.3 B | ||
|
ICU Medical
ICUI
|
107 M | $ 148.85 | -0.79 % | $ 3.63 B | ||
|
Ekso Bionics Holdings
EKSO
|
-1 K | $ 8.57 | 2.15 % | $ 173 M | ||
|
Alcon
ALC
|
192 M | $ 81.03 | -0.12 % | $ 40.4 B | ||
|
Repro Med Systems
KRMD
|
561 K | $ 5.39 | -1.1 % | $ 246 M | ||
|
AtriCure
ATRC
|
-326 K | $ 36.9 | -0.14 % | $ 1.73 B | ||
|
Haemonetics Corporation
HAE
|
-9.75 M | $ 66.55 | 0.88 % | $ 3.35 B | ||
|
electroCore
ECOR
|
6.3 M | $ 6.6 | -7.04 % | $ 36.4 K | ||
|
AngioDynamics
ANGO
|
4.94 M | $ 10.3 | 3.21 % | $ 421 M | ||
|
InfuSystem Holdings
INFU
|
1.4 M | $ 8.27 | 2.73 % | $ 171 M | ||
|
OraSure Technologies
OSUR
|
-380 K | $ 2.78 | -0.54 % | $ 207 M | ||
|
The Cooper Companies
COO
|
-16.4 M | $ 81.34 | 1.21 % | $ 16.2 B | ||
|
Masimo Corporation
MASI
|
300 K | $ 137.49 | 0.91 % | $ 7.33 B | ||
|
Harvard Bioscience
HBIO
|
-227 K | $ 0.5 | -6.73 % | $ 21.2 M | ||
|
Glaukos Corporation
GKOS
|
13.6 M | $ 119.29 | 0.28 % | $ 5.78 B | ||
|
Merit Medical Systems
MMSI
|
-711 K | $ 80.93 | 0.85 % | $ 4.71 B | ||
|
Isoray
ISR
|
2 K | - | 0.03 % | $ 108 M | ||
|
iRhythm Technologies
IRTC
|
1.25 M | $ 154.21 | 3.5 % | $ 4.81 B | ||
|
LeMaitre Vascular
LMAT
|
205 K | $ 84.97 | 1.32 % | $ 1.91 B | ||
|
STERIS plc
STE
|
8.4 M | $ 261.9 | 0.02 % | $ 25.8 B | ||
|
Utah Medical Products
UTMD
|
256 K | $ 61.21 | -0.71 % | $ 222 M | ||
|
Nephros
NEPH
|
2 K | $ 4.35 | -0.91 % | $ 45.2 M | ||
|
Milestone Scientific
MLSS
|
60.3 K | $ 0.29 | -2.67 % | $ 23.1 M | ||
|
Envista Holdings Corporation
NVST
|
-100 K | $ 23.4 | 0.13 % | $ 4.03 B | ||
|
Pro-Dex
PDEX
|
533 K | $ 38.77 | -1.61 % | $ 127 M | ||
|
Predictive Oncology
POAI
|
3 | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
983 K | $ 13.76 | 0.99 % | $ 661 M | ||
|
Becton, Dickinson and Company
BDX
|
613 M | $ 203.2 | 1.05 % | $ 58.5 B | ||
|
Repligen Corporation
RGEN
|
8.12 M | $ 150.44 | -3.8 % | $ 8.38 M | ||
|
ResMed
RMD
|
3.2 M | $ 256.15 | -0.57 % | $ 37.4 B | ||
|
BioLife Solutions
BLFS
|
497 K | $ 21.91 | -2.97 % | $ 1.01 B | ||
|
Stereotaxis
STXS
|
1.1 M | $ 2.21 | -5.36 % | $ 178 M | ||
|
Retractable Technologies
RVP
|
227 K | $ 0.7 | -1.03 % | $ 21 M | ||
|
STAAR Surgical Company
STAA
|
815 K | $ 18.9 | -0.24 % | $ 928 M | ||
|
Teleflex Incorporated
TFX
|
57 M | $ 104.44 | -0.96 % | $ 4.89 B | ||
|
West Pharmaceutical Services
WST
|
-1 M | $ 231.57 | -0.4 % | $ 16.9 B | ||
|
DENTSPLY SIRONA
XRAY
|
12 M | $ 12.47 | 1.63 % | $ 2.53 B |